• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

己酮可可碱治疗早产儿败血症:初步临床观察

Pentoxifylline treatment of sepsis of premature infants: preliminary clinical observations.

作者信息

Lauterbach R, Pawlik D, Tomaszczyk B, Cholewa B

机构信息

Neonatal Department, Jagiellonian University Medical College, Cracow, Poland.

出版信息

Eur J Pediatr. 1994 Sep;153(9):672-4. doi: 10.1007/BF02190690.

DOI:10.1007/BF02190690
PMID:7957428
Abstract

Pentoxifylline (Trental, 5 mg/kg/h for 6 h) was administered to 17 premature infants with sepsis, on 3 successive days. A statistically significant decrease in mortality rate (P < 0.04) was observed in comparison to a retrospectively analysed group of 13 septic infants, who were treated in a comparative way but without the use of a pentoxifylline infusion. The suggestion that pentoxifylline may be an effective drug in the treatment of Gram-negative sepsis in premature infants should be tested in a double-blind, randomized study.

摘要

对17名患有败血症的早产儿连续3天给予己酮可可碱(曲奥舒凡,5毫克/千克/小时,持续6小时)。与一组经回顾性分析的13名败血症婴儿相比,观察到死亡率有统计学意义的下降(P < 0.04),这组婴儿接受了对比治疗,但未使用己酮可可碱输注。己酮可可碱可能是治疗早产儿革兰氏阴性败血症的有效药物这一建议,应在双盲、随机研究中进行检验。

相似文献

1
Pentoxifylline treatment of sepsis of premature infants: preliminary clinical observations.己酮可可碱治疗早产儿败血症:初步临床观察
Eur J Pediatr. 1994 Sep;153(9):672-4. doi: 10.1007/BF02190690.
2
Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.免疫调节剂己酮可可碱治疗早产婴儿败血症的效果:一项安慰剂对照双盲试验
Crit Care Med. 1999 Apr;27(4):807-14. doi: 10.1097/00003246-199904000-00042.
3
Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis.己酮可可碱可降低败血症早产儿的血浆肿瘤坏死因子-α浓度。
Eur J Pediatr. 1996 May;155(5):404-9. doi: 10.1007/BF01955273.
4
Appraising the potential of pentoxifylline in septic premies.
Crit Care Med. 1999 Apr;27(4):695-7. doi: 10.1097/00003246-199904000-00017.
5
Protein C concentrate in preterm neonates with sepsis.脓毒症早产儿的蛋白C浓缩物
Acta Paediatr. 2009 Sep;98(9):1526-9. doi: 10.1111/j.1651-2227.2009.01404.x. Epub 2009 Jul 9.
6
Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates.己酮可可碱用于治疗新生儿败血症和坏死性小肠结肠炎。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD004205. doi: 10.1002/14651858.CD004205.pub2.
7
Pentoxifylline for neonatal sepsis.己酮可可碱用于新生儿败血症
Cochrane Database Syst Rev. 2003(4):CD004205. doi: 10.1002/14651858.CD004205.
8
Pentoxifylline therapy for late-onset sepsis in preterm infants: a randomized controlled trial.己酮可可碱治疗早产儿晚发性败血症:一项随机对照试验。
Pediatr Infect Dis J. 2015 Jun;34(6):e143-8. doi: 10.1097/INF.0000000000000698.
9
Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study.己酮可可碱治疗严重脓毒症的效果:一项随机、双盲、安慰剂对照研究的结果
Arch Surg. 1998 Jan;133(1):94-100. doi: 10.1001/archsurg.133.1.94.
10
Pentoxifylline and Pentaglobin adjuvant therapies for neonatal nosocomial sepsis in neonates less than 1500g weight.己酮可可碱和Pentaglobin辅助治疗体重小于1500克新生儿的医院感染性败血症
J Pak Med Assoc. 2017 Oct;67(10):1482-1486.

引用本文的文献

1
Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates.己酮可可碱治疗新生儿脓毒症和坏死性小肠结肠炎。
Cochrane Database Syst Rev. 2023 Jun 20;6(6):CD004205. doi: 10.1002/14651858.CD004205.pub4.
2
Protocol: Pentoxifylline optimal dose finding trial in preterm neonates with suspected late onset sepsis (PTX-trial).方案:早产儿疑似晚发性败血症(PTX 试验)中己酮可可碱最佳剂量的探索性试验。
BMC Pediatr. 2021 Nov 18;21(1):517. doi: 10.1186/s12887-021-02975-8.
3
Pentoxifylline as an adjunct therapy in children with cerebral malaria.

本文引用的文献

1
Pentoxifylline treatment of persistent pulmonary hypertension of newborn.己酮可可碱治疗新生儿持续性肺动脉高压
Eur J Pediatr. 1993 May;152(5):460. doi: 10.1007/BF01955916.
2
Oxpentifylline in endotoxaemia.己酮可可碱在内毒素血症中的应用。
Lancet. 1989;2(8678-8679):1474-7. doi: 10.1016/s0140-6736(89)92929-2.
3
Pretreatment with pentoxifylline improves the hemodynamic and histologic changes and decreases neutrophil adhesiveness in a pig fecal peritonitis model.在猪粪便性腹膜炎模型中,己酮可可碱预处理可改善血流动力学和组织学变化,并降低中性粒细胞黏附性。
己酮可可碱在儿童脑型疟疾中的辅助治疗作用。
Malar J. 2010 Dec 21;9:368. doi: 10.1186/1475-2875-9-368.
4
Pentoxifylline in preterm neonates: a systematic review.早产儿应用己酮可可碱的系统评价。
Paediatr Drugs. 2010 Oct 1;12(5):301-11. doi: 10.2165/11532600-000000000-00000.
5
New modalities for treating neonatal infection.治疗新生儿感染的新方法。
Eur J Pediatr. 1996 Aug;155 Suppl 2:S21-4. doi: 10.1007/BF01958076.
6
Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis.己酮可可碱可降低败血症早产儿的血浆肿瘤坏死因子-α浓度。
Eur J Pediatr. 1996 May;155(5):404-9. doi: 10.1007/BF01955273.
Crit Care Med. 1990 Feb;18(2):184-9. doi: 10.1097/00003246-199002000-00012.
4
Pentoxifylline lessens the endotoxin-induced increase in albumin clearance across pulmonary artery endothelial monolayers with and without neutrophils.己酮可可碱可减轻内毒素诱导的白蛋白通过肺动脉内皮单层(无论有无中性粒细胞)清除率的增加。
Am J Respir Cell Mol Biol. 1991 Mar;4(3):219-27. doi: 10.1165/ajrcmb/4.3.219.
5
Correlation of plasma cytokine elevations with mortality rate in children with sepsis.
J Pediatr. 1992 Apr;120(4 Pt 1):510-5. doi: 10.1016/s0022-3476(05)82476-x.
6
Effects of in vivo pentoxifylline treatment on survival and ex vivo vascular contractility in a rat lipopolysaccharide shock model.体内己酮可可碱治疗对大鼠脂多糖休克模型生存率及体外血管收缩性的影响
Circ Shock. 1992 Jan;36(1):74-80.
7
Increases in tumor response by pentoxifylline alone or in combination with nicotinamide.己酮可可碱单独使用或与烟酰胺联合使用时肿瘤反应的增加。
Int J Radiat Oncol Biol Phys. 1992;22(3):425-9. doi: 10.1016/0360-3016(92)90846-a.
8
Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.己酮可可碱对单核细胞和T细胞产生肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)的不同作用。
Immunology. 1992 May;76(1):30-4.